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Abstract
Background: Inactivating mutations of SMAD4 are frequent in metastatic colorectal carcinomas. In previous
analyses, we were able to show that restoration of Smad4 expression in Smad4-deficient SW480 human colon
carcinoma cells was adequate to suppress tumorigenicity and invasive potential, whereas in vitro cell growth was
not affected. Using this cellular model system, we searched for new Smad4 targets comparing nuclear
subproteomes derived from Smad4 re-expressing and Smad4 negative SW480 cells.
Methods: High resolution two-dimensional (2D) gel electrophoresis was applied to identify novel Smad4 targets in
the nuclear subproteome of Smad4 re-expressing SW480 cells. The identified candidate protein Keratin 23 was
further characterized by tandem affinity purification. Immunoprecipitation, subfractionation and immunolocalization
studies in combination with RNAi were used to validate the Keratin 23-14-3-3ε interaction.
Results: We identified keratins 8 and 18, heat shock proteins 60 and 70, plectin 1, as well as 14-3-3ε and g as novel
proteins present in the KRT23-interacting complex. Co-immunoprecipitation and subfractionation analyses as well
as immunolocalization studies in our Smad4-SW480 model cells provided further evidence that KRT23 associates
with 14-3-3ε and that Smad4 dependent KRT23 up-regulation induces a shift of the 14-3-3ε protein from a nuclear
to a cytoplasmic localization.
Conclusion: Based on our findings we propose a new regulatory circuitry involving Smad4 dependent up-
regulation of KRT23 (directly or indirectly) which in turn modulates the interaction between KRT23 and 14-3-3ε
leading to a cytoplasmic sequestration of 14-3-3ε. This cytoplasmic KRT23-14-3-3 interaction may alter the
functional status of the well described 14-3-3 scaffold protein, known to regulate key cellular processes, such as
signal transduction, cell cycle control, and apoptosis and may thus be a previously unappreciated facet of the
Smad4 tumor suppressive circuitry.
Background
The inactivation of the tumor suppressor DPC4 (deleted
in pancreatic carcinoma, locus 4), also called SMAD4 or
MADH4 is most frequently found in ductal pancreatic
adenocarcinomas (approx. 50%) and metastatic colon
carcinomas (approx. 30%) [1,2].
S m a d 4a n di t sh o m o l o g sm e d i a t es i g n a l sf r o mc y t o -
kines of the transforming growth factor-b (TGF-b)
family from cell surface receptors to the nucleus where
they regulate a diverse array of target genes involved in
numerous biological functions including embryonic
development, cell growth and differentiation, modula-
tion of immune responses, and bone formation.
Ligand induced TGF-b receptor stimulation leads to
the formation of a hetero-tetrameric receptor complex
of two identical heterodimers, which is comprised of a
type I and a type II receptor family member, each. Upon
receptor activation the receptor-regulated Smads (R-
Smads) can transiently interact with the type I receptor.
R-Smads are thereby C-terminally phosphorylated by
the receptor kinase and, once phosphorylated, they form
a hetero-oligomeric complex with the “common-
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nucleus, where it regulates the transcription levels of
target genes by interacting with other transcription fac-
tors and by recruiting transcriptional co-activators or
co-repressors [3]. In addition to R-Smads there are also
inhibitory Smads (I-Smads) and other signaling mole-
cules that feed into the TGF-b-Smad signalling cascade
such as ERK, JNK and PKC [4].
This rather complex mode of target gene regulation
involving Smad4 explains why currently more than 1000
genes were described to be either directly or indirectly
regulated by Smad4 [5]. Furthermore, it is obvious that
the cellular context will play a crucial role in defining
the subset of Smad4 target genes relevant in a particular
cellular differentiation state.
In the current work, we focused on colon carcinoma
(SW480) cells to define potential Smad4 target genes
involved in the neoplastic transformation process of this
particular cell type. For the detailed investigation of
Smad4’s tumor suppressor functions, we stably re-
expressed Smad4 via gene transfer in human Smad4-
deficient SW480 tumor cells [6]. We were able to show
that re-expression of Smad4 in these colon carcinoma
cells was not sufficient to restore TGF-b responsiveness.
These cells have accumulated a number of other onco-
genic alterations in addition to and presumably prior to
Smad4 inactivation [6,7], likely explaining the TGF-b
resistance of Smad4 re-expressing derivatives. However,
the re-expression of Smad4 in SW480 cells was suffi-
cient to suppress tumor growth in vivo [6] confirming
that these cells provide an adequate model to investigate
Smad4 tumor suppressor function.
Here we focused on the study of the nuclear subpro-
teome of Smad4 re-expressing SW480 cells in compari-
son to its Smad4 negative cells by establishing a
subfractionation strategy coupled with the difference gel
electrophoresis (DIGE) system and subsequent MALDI-
MS-based peptide mass fingerprinting (PMF) to identify
differentially expressed proteins.
Of the proteins which were identified as highly up-
regulated in Smad4 re-expressing SW480 cells, we chose
to follow-up on the KRT23 protein. Keratins are major
structural proteins in epithelial cells. The keratin multi-
gene family contains 50 individual members, which can
be divided in two groups: (i) acidic forms and (ii) basic
forms. The KRT9-23 belongs to the acidic group,
whereas KRT1-8 are basic keratins [8]. Generally, one
basic and one acidic keratin heterodimerize in order to
form a functionally active intermediate filament. It has
been postulated that the mechanical properties of these
dimers are regulated by their specific keratin composi-
tion [9]. An association of differential expression pat-
terns of keratins with tumor progression and the utility
of measuring the keratin expression status for a
differentiation between normal und tumor cells has
been established [10-13]. Furthermore, it has been
shown that in normal cellular senescence primary
KRT8/18, i.e. keratins that are expressed first during tis-
sue development, become partly substituted by second-
ary or later keratins (e.g. KRT20, KRT7) in a tissue
dependent manner. This effect, however, is disrupted in
transformed cells and thus expression profiling of kera-
tins can be used for cancer diagnosis, i.e. the type of
keratin detected allows the distinction between normal
and cancerous tissue and for the definition of the type
of carcinoma, even when the tumor is present as metas-
tasis of unknown origin [14-16]. More recently, the clas-
sical structural role of keratins was extended to their
involvement in cell signalling, stress response and apop-
tosis, mostly through their interaction with other pro-
teins and/or their phosphorylation, glycosylation,
transglutamination, caspase cleavage and ubiquitination
state affecting keratin organization, distribution, turn-
over and function [17]. In colorectal microsatellite
instable tumors the over-expression of KRT23 led to
cell death. Due to this cellular response KRT23 was
associated with a potential role as a tumor suppressor in
this subset of colorectal cancers [18].
In this work we present data showing the interaction
between 14-3-3 proteins and KRT23. The 14-3-3 protein
family consists of 7 isoforms in mammalian cells (b, g, ε,
h, s, τ, ξ) which form homo- and hetrerodimers with
each other [19]. These dimers bind preferentially to the
phosphorylated motifs RSXpSXP and RXXXpSXP pre-
sent on most known 14-3-3 binding proteins [20]. The
universal nature of this protein family has been shown
using proteomic approaches [21-24]. The identified
broad spectrum of 14-3-3 interacting partners illustrates
the vast array of processes in which this protein family
is involved. Based on the discovery of cytoplasmic
sequestration of BAD a general sequestration model was
postulated [25]. The core of this sequestration model is
a nuclear export signal (NES)-like domain within the
14-3-3 molecules that bind to target proteins. Upon
binding, NES sequences of the target proteins become
exposed, which initiates translocation of the target pro-
tein from the nucleus into the cytoplasm thereby inhi-
biting the activity of the target molecule [26,27]. As
numerous 14-3-3 interaction partners have been impli-
cated in apoptosis and cell cycle regulation, it is not sur-
prising that 14-3-3 proteins play a crucial role in
carcinogenesis. Examples are the sequestration of
CDC25s and p21 through 14-3-3ε [28-31].
H e r e ,w er e p o r tt h a tr e - e x p r e s s i o no fS m a d 4i nt h e
SW480 cells strongly induces KRT23 expression, both at
the transcript and protein level. A tandem affinity purifi-
cation (TAP) assay with KRT23 as bait was performed
to identify KRT23 interacting proteins. This assay
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plex and that Smad4 re-expression and KRT23 up-regu-
lation correlates with cytoplasmic translocalization of
14-3-3ε.I ns u m m a r y ,o u rd a t as u g g e s tt h a tS m a d 4 -
dependent KRT23 expression is probably important for
the cellular localization of 14-3-3ε. This, in turn, will
likely influence cellular signaling through 14-3-3 binding
partners involved - amongst others - in cell cycle, intra-
cellular trafficking/targeting and signal transduction; all
these processes are known to be altered in
carcinogenesis.
Methods
Reagents and Cell culture - Monoclonal anti-tubulin
(TUB2.1) and anti-FLAG (M2) antibodies were pur-
chased from Sigma. Anti-lamin B (C-20) and anti-VSV-
G (P5D4) antibodies were purchased from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). Human embryo-
n i ck i d n e y( H E K )2 9 3 Tc e l l sa sw e l la sS m a d 4n e g a t i v e
and re-expressing derivatives of the colon carcinoma
cell line SW480 [32] were cultured in DMEM media
supplemented with 10% FBS and antibiotics.
DNA Constructs and Transient Transfection - cDNAs
encoding the wild type FLAG-tagged KRT23 was ampli-
fied by PCR and ligated into the SalI-EcoRI site of the
pMT2SM expression vector. The expression vector for
VSV-G-tagged 14-3-3ε (pcDNA3-VSV-G-14-3-3ε)w a s
kindly donated by H. Hermeking (LMU München, Ger-
many). Cells were seeded onto 10 cm dishes 18 to 24 h
prior to transfection and then transiently transfected at
60 to 70% confluence using FuGENE-6 transfection
reagent (Roche Diagnostics). 48 h after transfection,
cells were harvested for further assays.
Immunoprecipitation, Cell Fractionation and Immuno-
blotting - Smad4 re-expressing and Smad4 negative
SW480 cells were lysed in ice cold RIPA buffer to pre-
pare whole cell lysates. Lysates were cleared by centrifu-
gation. HEK 293T cells were transfected with Flag-
KRT23 and/or VSV-G-14-3-3ε expression vectors.
Transfected cells were lysed in RIPA buffer to prepare
whole cell lysates. Immunoprecipitation was performed
using ANTI-FLAG M2-affinity agarose, with constant
agitation overnight at 4°C. After extensive washes, pro-
teins bound to the beads were eluted with denaturing
Laemmli buffer. To isolate nuclear and cytoplasmic frac-
tions, cells were washed twice with cold PBS and resus-
pended in 500 μl of hypotonic buffer (20 mM Tris-HCl
pH 7.4, 5 mM MgCl2, 1.5 mM KCl, 0.1% NP-40, 50
mM NaF, 2 mM sodium orthovanadate, and protease
inhibitors (Complete, Roche)). Cells were allowed to
swell on ice for 10 min and then passed several times
through a 26 1/2 gauge syringe needle, followed by cen-
trifugation at 800 × g. The supernatants were further
centrifuged at 15,000 × g to remove insoluble pellets,
and the resulting supernatants were collected as the
cytoplasmic fractions. The pellets were resuspended in
100 μl of TKM buffer (20 mM Tris-acetate pH 7.4, 50
mM KCl, 5 mM MgCl2, containing protease and phos-
phatase inhibitors). After centrifugation at 15,000 × g
for 10 min, the supernatants were collected like the
nuclear fractions. Whole cell lysates from SW480 cells,
immunoprecipitated proteins and proteins derived from
cell fractionation were subjected to SDS-PAGE and
transferred onto polyvinylidinedifluoride membranes
(Millipore), respectively. The membranes were incubated
with the indicated antibodies followed by the corre-
sponding secondary antibodies. The membranes were
then developed with the ECL Western Blotting Detec-
tion System (Pierce).
Protein Isolation from Nuclear Fractions for 2D-PAGE
Analyses - For nuclear fractionation and protein isola-
tion 10 cell culture dishes (10 cm) each from Smad4 re-
expressing and Smad4 negative SW480 cells were har-
vested. Cell breakage was done following swelling cells
in hypotonic buffer (10 mM Tris, pH 7.4, 10 mM NaCl,
5 mM MgCl2, 0.5% Triton X-100) with a dounce homo-
genisator. Broken cells were centrifugated (1,000 × g, 4°
C, 10 min) to collect a crude nucleus fraction. The
nuclei containing pellet was transferred onto an iodixa-
nol density step gradient (25%, 30%, 35% (v/v)). Separa-
tion over the gradient was done by centrifugation
(16,000 × g, 4°C, 30 min) and the nucleus fraction was
collected at the interphase located approximately
between the 30% (v/v) and 35% (v/v) iodixanol. The col-
lected fraction was subsequently diluted 1:2 in TKM
buffer (20 mM Tris, pH 7.4, 250 mM Sucrose, 50 mM
KCl, 5 mM MgCl2; supplemented with protease inhibi-
tors). Resuspended nuclei were centrifugated (1,000 × g,
4°C, 20 min) and washed two additional times in TKM
buffer. The harvested nuclei were snap frozen in liquid
nitrogen and stored at -80°C until 2D-PAGE separation.
2D Gel Electrophoresis - Collected nuclear fractions
were dissolved in DIGE buffer (30 mM Tris, pH 8.5, 2 M
thiourea, 7 M urea, 4% CHAPS). For a minimal labeling
of proteins with CyDyes (GE Healthcare) 50 μgp r o t e i n
was incubated with 400 pmol CyDye dissolved in anhy-
drous DMF p.a. After 30 min of incubation in the dark
on ice 10 pmol lysine was added to stop the labeling reac-
tion. Cy3 and Cy5 labels were used for Smad4 negative
and Smad4 positive samples, respectively. As internal
standard pooled lysates of nuclear fractions containing
equal amounts of protein, each, from Smad4 re-expres-
sing and negative cells were Cy2 labeled. After combining
all three samples the mixture was applied on the IEF tube
gel (20 cm × 0.7 mm). The IEF was performed with car-
rier ampholyte tube gels with an ampholyte mixture ran-
ging from pH 2-11 for 8.05 kVh. After IEF tube gels were
ejected, incubated in equilibration buffer (125 mM Tris
Liffers et al. BMC Cancer 2011, 11:137
http://www.biomedcentral.com/1471-2407/11/137
Page 3 of 14pH 6.8, 40% (w/v) Glycerol, 3% (w/v) SDS, 65 mM DTT)
for 10 min and subsequently applied on the second
dimension gel (20 cm × 30 cm × 0.7 mm). The second
dimension (SDS-PAGE) consisted of 15.2%T, 1.3%C
polyacrylamide gels which were run in a Tris-Glycine
buffer system. For protein identification the preparative
gel format was: 20 cm × 1.5 mm for tube gels and 20 cm
× 30 cm × 1.5 mm for SDS-PAGE.
Image Analysis - CyDye labeled proteins were visua-
lized by Typhoon 9400 laser scanner (GE Healthcare)
according to the user manual. Image analysis was per-
formed with the DIA software tool (GE Healthcare) for
single gel comparison and the Biological Variance Ana-
lysis (BVA) software tool (GE Healthcare) in case of
matching gel sets. Parameters for significant changes in
the spot pattern were set as follows: changes in the spot
volume had to be two-fold, p-value of Student’s T-test
had to be ≤ 0.05 and the spot had to be detected in at
least five of six gel sets.
Tryptic in-gel Digestion and MALDI-MS Protein Iden-
tification - For protein identification, silver stained pro-
tein spots or bands of interest were cut from a
preparative gel, in-gel digested with trypsin (Promega,
Madison, WI) and extracted as described previously [33].
For MALDI-MS target preparation peptides were con-
centrated via ZipTips™, eluted on the MALDI-target
with 1.2 μLm a t r i xs o l u t i o n( a-cyano-4-hydroxy cin-
namic acid in ACN and 0,1% (v/v) TFA (1:2)) and ana-
lyzed using the UltraflexTM (Bruker Daltoniks). PMF
s p e c t r aw e r ea c q u i r e di np o s i t i v em o d ew i t h2 0k Vt a r -
get voltage and pulsed ion extraction of 17.25 kV. The
reflector and detector voltage was set to 21 kV and 1.7
kV, respectively. Peak detection was carried out using
FlexAnalysis 1.2 (Bruker Daltonics) with a S/N threshold
of 2.5. The monoisotopic peptide mass values were
transferred to ProteinScape™ (Bruker Daltonics) for
subsequent protein identification via automated database
analysis against the human IPI (V3.27; 67528 entries) by
Profound (2002.03.01). To confirm the results obtained
a randomized database combined with a normal IPI
human database was performed. Searches were carried
out with a mass tolerance of 100 ppm. Furthermore,
propionamide (C, +71 Da) was set as a fixed and oxida-
tion (M, +16 Da) as a variable modification and for the
cleavage enzyme (trypsin) one missed cleavage site was
allowed. Internal re-calibration of the obtained data was
performed using a calibrant list and contained mass
values were subsequently excluded prior database
search. A Z score of 1.65 was used as threshold for the
protein identification.
Protein Identification of TAP Purified Proteins - The
Protein identification of TAP purified proteins were
done by liquid chromatography (LC)-tandem MS (MS/
MS). LC-MS/MS measurements were done with tryptic
peptide extracts in 5% (v/v) FA by using a LC Packings
Ultimate capillary LC system coupled to 4000 Q Trap™
(Applied Biosystems). Ionspray voltage was set to 3.0 -
3.2 kV in positive mode. EMS-scan was performed over
a mass range from 400 to 1400 m/z. For MS/MS-scans
the three highest signals were isolated and fragmenta-
tion was done with collision energy between 15-60 V
according to m and z. MGF data were extracted from
the raw data using Analyst 1.4.1 (Applied Biosystems)
and Mascot (2.2.0) was used for database searches
against the human IPI (V3.27; 67528 entries). To con-
firm the results, a randomized database combined with
a normal IPI human database was performed. The mass
accuracy was set to 1.5 Da for precursor ions and 0.5
Da for fragment ions. Further modification of cysteine
by propionamide (C, +71 Da) was set as a fixed modifi-
cation and oxidation of methionine (M, +16 Da) was set
as a variable modification. One missed cleavage site for
the tryptic digestion was allowed. Proteins were identi-
fied with three different peptides with an ion score of 32
and higher.
RNA Isolation and Northern Blotting - Total RNA
was prepared from Smad4 re-expressing and negative
cells as described previously [6]. Briefly, 5 μg total RNA
was applied on 1% formaldehyde-agarose gel. Subse-
quently the gel was blotted onto Hybond N membranes
(Amersham) with SSC buffer (0.15 M Sodium citrate
pH 7.0, 1.5 M NaCl) and filters were hybridized at 50°C
overnight with radiolabeled probes using the following
oligonucleotides 5’-cgcgtcgaccaccatggactacaaggacgacgat
gacaagaactccggacacagcttcag-3’ and 5’-acagaattcaaca-
ggcggaaactttcattg-3.
Production of Transgenic TAP-KRT23 SW480 Cells -
The coding region of KRT23 was PCR-amplified from
an image clone using the oligonucleotides 5’-caattgaactc
cggacacagcttcag-3’ and 5’-gtcgactcatgcgtgcttttggattt-3’.
The resulting PCR-products were inserted into the
MfeI, SalI site of retroviral vector pBabe-puro. The TAP
affinity tag was amplified from pRAV-FLAG (kindly pro-
vided by X. Liu, University of Colorado, Boulder, CO,
USA) with the oligonucleotides 5’-cgggatccatggcgcaacac-
gatgaagc-3’ and 5’-gccaattgcttgtcatcgtcgtccttg-3’.R e s u l t -
ing PCR-fragments were digested with BamHI and MfeI
and subsequently ligated into the pBabepuro vector con-
taining the KRT23 sequence. The correct insert
sequences of the newly generated pBabeTAP-KRT23
vector were confirmed by cycle sequencing analysis.
Generation of the TAP-KRT23 expression cassette con-
taining retrovirus was done in HEK 293T cells. Trans-
fection of HEK 293T cells was done with FuGene
(Roche) according to the manufacturer’s instructions.
For retroviral virus particle generation the packaging
pHIT60 and the envelope pHITG plasmids were
cotransfected together with the pBabeTAP-KRT23
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done with filtered (0.45 μm pore size) retroviral particles
released from 293T cells. Transduced SW480 cells were
selected with 2 μg/mL puromycin (Sigma).
Tandem Affinity Purification (TAP) - SW480 cell lines
stably expressing the TAP-tagged KRT23 protein were
cultured in 14.5 cm culture dishes. Confluent SW480
cells from 15 dishes were used in each purification
experiment. Before lysis, cells were washed three times
with cold PBS and then lysed directly on the dish (50
mM Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1 mM
DTT, 2% (v/v) Trition X-100, 50 mM NaF, 2 mM
NaVO4 and protease inhibitor cocktail (complete mini,
Roche)). After preclearing the samples (2 × 10 min, 1,000
× g, 4°C) the supernatants were incubated with 100 μL
IgG-Sepharose (GE Healthcare) for 1 h at 4°C, followed
by a washing step with cleavage buffer (50 mM Tris, pH
7.4, 150 mM NaCl, 5 mM EDTA, 1 mM DTT, 2% (v/v)
Trition X-100, 50 mM NaF, 2 mM NaVO4)a n ds u b s e -
quent TEV cleavage in 200 μl cleavage buffer with 100
units of TEV protease (Invitrogen). The TEV eluate was
transferred onto 50 μL ANTI-FLAG M2-Agarose (Sigma)
and incubated for 1 h at 4°C. After extensively washing
the agarose beads were treated with 50 μl elution buffer
(62.5 mM Tris pH 6.8, 2% (w/v) SDS, 10% (w/v) Gly-
cerin) for 3 min at room temperature.
Confocal Laser Scanning Microscope Analysis - SW480
cells were seeded on glass coverslips. After 48 h cells
were fixed in 3.5% (v/v) paraformaldehyde and permeabi-
lized with 0.2% (v/v) Triton X-100. Before primary anti-
bodies were applied (a-Flag M2 (mouse, Sigma); a-14-3-
3ε (rabbit, Santa Cruz); a-b-tubulin (mouse, Sigma)) cells
were blocked with 1% BSA. Secondary antibodies were
labeled as followed: a-mouse IgG-FITC (Dianova) and a-
rabbit IgG-TRITC (Dianova).I m a g e so fi m m u n o s t a i n e d
cells were generated with a Leica TCS SP2 confocal laser
scanning microscope and processed with the Leica Con-
focal Software Version 2.5, build 1227.
ShRNA Down-Regulation of Keratin 23 in SW480
cells - Keratin 23 expression cells was silenced in
SW480 cells by shRNAknock-down. The following oli-
gonucleotide pairs KRT23-1506s: 5’-CCGGGCAC-
GAAATCTGCTTTGGAAAGCTCGAGGTTTCCAA
AGCAGATTT CGTGCTTTTTG-3’, KRT23-1506as: 5’-
AATTCAAAAAGCACGAAATCTGCTTTGGAA ACC
TCGAGCTTTCCAAAGCAGATTTCGTGC-3’ and KR
T23-1010s: 5’-CCGGGCTCAG ATTATTCTTCTCAT
TGCTCGAGGAATGAGAAGAATAATCTGAGCTT
TTTG-3’; KRT23-1010as: 5’-AATTCAAAAAGCTCAG
ATTATTCTTCTCATTCCTCGAGCAATGA GAAG
AATAATCTGAGC-3’ were annealed and subcloned
into the EcoRI/AgeI site of the pLKO.1 puro vector
(kindly provided by Sheila Stewart). Lentiviruses were
made by transfecting packaging cells (HEK 293T) with a
3-plasmid system. DNA for transfections was prepared
by mixing 12 μg pCMVΔRR8.2, 1 μg pHIT G and 12 μg
pLKO.1 plasmid DNA with 62 μlo f2MC a C l 2 in a
final volume of 500 μl. Subsequently 500 μlo f2 xH B S
phosphate buffer was dropwise added to the mixture
and incubated for 10 min at RT. The 1 ml transfection
mixture was added to 50% confluent HEK 293T cell
seeded the day before into a 10 cm well plate. Cells
were incubated for 16 h (37°C and 10% CO2), before the
media was changed to remove remaining transfection
reagent. Lentiviral supernatants were collected at 36 h
post-transfection and for each infection 3 ml superna-
tant containing 4 μg/ml polybrene was immediately
used to infect target cells seeded the day before in 6
well plates to reach 70% confluency on the day of infec-
tion. Cells were incubatedf o r2 4h ,a n dt h em e d i aw a s
changed to remove virus particles. To control infection
rate a parallel infection under the identical conditions
targeting the same cell line was prepared using a lenti-
viral GFP expression control vector (pRRLU6-CPPT-
pSK-GFP, kindly provided by Sheila Stewart). 6 days
after infection 2 μg/ml puromycin was added to the cell
culture media. The knock-down efficiency was moni-
tored by qRT-PCR using the SYBR Green Master Mix
reagent (Applied Biosystems) and a 7700 Sequence
Detector System (Applied Biosystems). Relative Expres-
sion changes are calculated relative to B2M (B2Ms:
TGCTGTCTCCATGTTTGATGT ATCT and B2Mas:
TCTCTGCTCCCCACCTCTAAGT). The KRT23
expression was measured using the following oligonu-
cleotide pairs: KRT23s: GAACTGGAGCGGCAGA ACA
and KRT23as: TTGATTCTTCCCGTGTCCCTT.
Results
Differential protein profiling of nuclear proteins from
Smad4 deficient and Smad4 re-expressing SW480 cells
Smad4 re-expressing SW480 cells served as a model sys-
tem to investigate the effects of the tumor suppressor
Smad4 reconstitution on the nuclear protein composi-
tion of human colon carcinoma cells. Using 2D-DIGE
analysis, we compared nuclear protein fractions derived
from six independent replicates of Smad4 re-expressing
and Smad4 negative SW480 cells, respectively (Figure
1A-C). We generated 3 sample sets each, derived from
Cy3 labeled Smad4 re-expressing cell lysates and Cy5
labeled Smad4 negative cell lysates, whereas the second
sample set (again three lysates, each for Smad4 re-
expressing and negative cells) was labeled vice versa to
minimize the identification of false positive protein
spots. On average about 2000 spots were detected per
gel. In the subsequent image analysis, using the DeCyder
software (GE Healthcare), a total of 17 spots were iden-
tified that show a reproducible differential expression
pattern. We considered intensity differences of factor
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expressed protein spots covered the entire pI and mole-
cular weight range of the 2D-gels (Figure 1A). Of these
17 spots, 14 showed a higher and three a lower abun-
dance in the nuclear fraction upon Smad4 re-expression.
The subsequent protein identification by MALDI-MS
revealed eight unique proteins (Table 1). The sequence
coverage of these proteins ranged from 12.6 - 60.2%
with Profound scores between 1.0 - 2.5 (1.3 being signif-
icant). The following proteins were found to be induced
upon Smad4 re-expression: tumor rejection antigen
(gp96), heterogeneous nuclear ribonucleoprotein R,
eukaryotic translation elongation factor 1 alpha 1,
KRT23, KRT18 and Cyclophilin A. In contrast, the
amount of KRT8 and RbAp46 was found to be reduced
in the nuclear fraction.
Keratin 23 up-regulation occurs at the transcription level
in a Smad4 dependent manner
As it is well known that the expression profiles of kera-
tins change significantly during tumor progression and
the consequences of these changes have dramatic effects
on the morphology of the cells, we chose to study
KRT23 further. About this particular keratin very little
is known and our data clearly showed different expres-
sion levels in a Smad4-dependent context (Figure 1A,
Spot 10 and 11), i.e. a threefold up-regulation in Smad4
re-expressing cells (Figure 1B, C). Subsequent Northern
blot analysis of Smad4 re-expressing and negative
SW480 cells confirmed the Smad4-dependent up-regula-
tion already at the transcription level (Figure 1D). Hav-
ing identified and confirmed the proteome data of the
novel Smad4 target protein KRT23, we sought to iden-
tify protein interaction partners of this uncommon and
poorly characterized keratin as an initial step to gather
functional information for KRT23.
Generation of stably expressing TAP-Keratin 23 cell lines
To analyze the interaction partners of KRT23, we chose
to perform a tandem affinity purification assay [34]. The
N-terminal tag used for this experiment consists of a
Flag-tag followed by two TEV cleavage sites and two
Figure 1 Differential proteome analysis of Smad4 re-expressing and negative SW480 cells. A) A representative example of the 2D-DIGE
analyses is shown. Differentially expressed proteins are labeled by an arrow. The protein spot signals derived from the nuclear lysates of Smad4
negative cells are shown in green and those from Smad4 re-expressing cells in red. The protein names corresponding to each numbered spot
are given in table 1. Spot numbers 10 and 11 mark the KRT23 spots. B) and C) Expression levels of the two KRT23 spots relative to the protein
standard according to the dye swop experiment (neg., Smad4 negative SW480 cells; pos., Smad4 re-expressing SW480 cells) D) Expression of
KRT23 analyzed by Northern blotting.
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Page 6 of 14Protein Z domains. Due to the generally poor transfec-
tion efficiency of SW480 cells with standard plasmid
transfection strategies, we opted for retroviral gene
transfer to generate Smad4 negative and Smad4 re-
expressing SW480 cells which stably express the trans-
genic TAP-KRT23 protein. This approach offered a
rapid and reliable means to purify native protein com-
plexes and to identify the proteins by mass spectrometry
[34]. The successful expression of the TAP-KRT23 pro-
tein was monitored by Western blotting (data not
shown). In addition we analyzed the distribution of the
over-expressed TAP-KRT23 by confocal microscopy.
The immunofluorescence data revealed that the overex-
pressed protein is exclusively localized in the cytoplasm
and surrounding the nucleus. Furthermore we observed
a characteristic filamentous structure as expected for a
member of the keratin family (Figure 2A, B).
Tandem Affinity Purification of Keratin 23
KRT23 interaction partners were isolated following the
TAP-strategy. Therefore, KRT23 protein complexes from
Smad4 re-expressing and Smad4 negative cells were first
affinity purified using IgG-Sepharose prior to TEV clea-
vage, followed by a second affinity purification step using
immobilized ANTI-FLAG M2-Agarose. The FLAG elu-
ates from the second purification step were separated by
SDS-PAGE and the proteins visualized by silver staining.
Five bands were present in both samples (Figure 2C,
Bands 1 - 4 and 6), whereas two protein bands were
unique to the Smad4 re-expressing cell line (Figure 2C,
Bands 7 and 8). All bands were excised and in-gel
digested with trypsin prior to analysis by nanoLC-MS/
MS (Table 2). We were able to verify that the common
bands contain the same set of proteins including, Plectin
isoform 11, HSP70, HSP60, KRT8, KRT18. These
proteins correspond to typical keratin-associated pro-
teins. Two protein bands of approximately 30 kD, which
were only detected in the Smad4 re-expressing cells,
were identified as 14-3-3ε and 14-3-3g, respectively.
Validation of Keratin 23-14-3-3ε-Interaction
To further investigate the Smad4-dependent interaction
between 14-3-3 and KRT23, we analyzed the endogenous
Table 1 Smad4 target proteins identified by DIGE coupled with MALDI-TOF-MS
Spot
No
Accession No Protein Profound
Score
Sequence
coverage
No. of Peptides
matched detected
1 gi|44890631 tumor rejection antigen (gp96) 1 2.4 14.6 15 21
3 gi|5031755 heterogeneous nuclear ribonucleoprotein R 2.5 23.4 12 20
4 gi|181573 cytokeratin 8 2.4 29.0 11 15
6 gi|4506439 retinoblastoma binding protein 7 2.4 26.4 12 20
7 gi|4503471 eukaryotic translation elongation factor 1 alpha 1 1.0 12.6 6 13
8 gi|4503471 eukaryotic translation elongation factor 1 alpha 1 1.8 20.3 8 20
9 gi|4503471 eukaryotic translation elongation factor 1 alpha 1 1.3 18.8 6 20
10 gi|27894339 cytokeratin 23 2.4 60.2 26 47
11 gi|27894339 cytokeratin 23 2.2 34.4 17 26
15 gi|30311 cytokeratin 18 2.4 22.9 12 21
16 gi|1633054 cyclophilin A 2.2 48.2 12 23
17 gi|1633054 cyclophilin A 1.6 51.2 7 20
Only spots with unequivocal identification by MALDI-TOF-MS are included in this table.
Figure 2 Tandem affinity purification of Keratin 23. Confocal
immunofluorescence images of SW480 cells overexpressing KRT23.
A) Smad4 re-expressing SW480 cells B) Smad4 negative SW480 cells.
KRT23 was visualized by a-Flag M2 antibody. C) FLAG eluates from
the tandem affinity purification experiments with TAP-KRT23 were
separated on a standard 1D-PAGE and proteins visualized by silver
staining. The protein names corresponding to each numbered band
given in table 2.
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Page 7 of 14Table 2 KRT23 interacting proteins identified by TAP
followed by LC-MS/MS
Lane
no.
NCBI
accession no.
Protein
identified
Peptides Mascot
Score
1 gi|40849944 plectin 1
isoform 11
ELYQQLQR 59
LSVAAQEAAR 56
FAEQTLR 46
LAAIGEATR 46
LTVDEAVR 44
DLSELGSVR 41
GLVEDTLR 41
VSIYEAM*R 33
DVAEVDTVR 32
2 gi|5729877 HSP70 NQVAM*NPTNTVFDAK 76
VEIIANDQGNR 74
DAGTIAGLNVLR 73
LLQDFFNGK 45
EIAEAYLGK 43
NSLESYAFNM*K 38
LIGDAAK 35
ITITNDK 33
3 gi|31542947 HSP60 NAGVEGSLIVEK 85
VTDALNATR 75
VGGTSDVEVNEK 63
VGLQVVAVK 62
TVIIEQSWGSPK 59
LSDGVAVLK 52
DDAM*LLK 47
EIGNIISDAM*K 45
APGFGDNR 43
IGIEIIK 41
VGEVIVTK 41
NAGVEGSLIVEK 33
4 gi|181573 cytokeratin
8
YEELQSLAGK 73
LSELEAALQR 71
SLDM*DSIIAEVK 65
ASLEAAIADAEQR 59
KLLEGEESR 57
LESGM*QNM*SIHTK 56
TEM*ENEFVLIK 55
LQAEIEGLK 55
ISSSSFSR 55
SLDM*DSIIAEVK 52
ELQSQISDTSVVLSM*DNSR 48
TEISEM*NR 46
LLEGEESR 45
SRAEAESM*YQIK 44
FASFIDK 44
NKYEDEINKR 40
DVDEAYM*NK 38
SYTSGPGSR 36
GELAIK 35
Table 2 KRT23 interacting proteins identified by TAP fol-
lowed by LC-MS/MS (Continued)
AEAESM*YQIK 34
YEDEINKR 33
QLYEEEIR 33
FLEQQNK 33
5 gi|20306864 cytokeratin
23
SALENM*LSETQSR 106
EQSAAM*SQEAASPATVQSR 59
DLEIEVEGLR 58
LLEGESEGTR 57
ATM*QNLNDR 56
AITQETINGR 49
MAVDDFNLK 47
M*AVDDFNLK 47
ISLSFTTR 44
YENEHSFK 42
LASYVEK 40
APTVHGGAGGAR 38
ALEEANM*K 35
6 gi|30311 cytokeratin
18
AQIFANTVDNAR 80
LEAEIATYR 70
TVQSLEIDLDSM*R 67
ETM*QSLNDR 53
LASYLDR 51
LAADDFR 50
KVIDDTNITR 46
VIDDTNITR 45
STFSTNYR 43
SLETENR 42
AQYDELAR 40
YETELAM*R 38
DWSHYFK 36
7 gi|67464424 14-3-3 ε VAGM*DVELTVEER 95
EAAENSLVAYK 84
YLAEFATGNDR 72
HLIPAANTGESK 54
LAEQAER 50
DSTLIM*QLLR 48
YDEM*VESM*K 47
IISSIEQK 44
QM*VETELK 36
NLLSVAYK 33
8 gi|21464101 14-3-3 g NVTELNEPLSNEER 71
YLAEVATGEK 66
LAEQAER 62
DSTLIM*QLLR 58
YDDM*AAAM*K 56
NLLSVAYK 55
VISSIEQK 42
ATVVESSEK 40
AYSEAHEISK 35
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Page 8 of 14expression of 14-3-3ε and 14-3-3g in Smad4 re-expressing
and Smad4 negative SW480 cells. The Western blot analy-
sis showed that the expression of 14-3-3 proteins was
reduced in Smad4 negative SW480 cells, compared to
Smad4 re-expressing cells (Figure 3A). We chose to focus
on the 14-3-3ε isoform for further analysis, because 14-3-
3g is known to form heterodimers with any other 14-3-3
family member whereas 14-3-3ε is only associated with
the 14-3-3g isoform. Using tagged proteins (Flag-KRT23
and VSV-G-14-3-3ε) in an immunoprecipitation experi-
ment we were able to confirm our finding from the TAP-
assay showing that KRT23 is an interaction partner of 14-
3-3ε (Figure 3B). Having confirmed that 14-3-3ε is a
KRT23 interaction partner, and taking into account pre-
vious findings by others showing that keratins
are important for nuclear redistribution of 14-3-3 proteins
[35,36], we went on to analyze whether KRT23 expression
is able to modulate the cellular distribution of 14-3-3ε or
not. HEK 293T cells overexpressing VSV-G-14-3-3ε were
fractionated into cytoplasmic and nuclear fraction and the
protein signal for VSV-G-14-3-3 could be recovered in
both fractions. The co-expression of Flag-KRT23 and
VSV-G-14-3-3 in turn lead to a decline of the VSV-G-14-
3-3ε signal in the nuclear fraction, thus experimentally
supporting a model where KRT23 expression is indeed
influencing the cellular distribution of 14-3-3ε (Figure 3C).
Cellular distribution of 14-3-3ε in SW480 cells depends on
Keratin 23
Having shown a link between KRT23 expression and 14-
3-3ε localization, we further hypothesized that Smad4
re-expression in our SW480 cell model system (also
shown to induce KRT23 expression) could have a simi-
lar effect on the endogenous cellular localization of 14-
3-3ε. Indeed, confocal imaging revealed that in Smad4
re-expressing SW480 cells 14-3-3ε is more prominently
Figure 3 Interaction of Keratin 23 with 14-3-3ε. A) Endogenous 14-3-3ε and 14-3-3g expression levels of Smad4 re-expressing and Smad4
negative SW480 cells. 20 μg whole cell lysates derived from Smad4 re-expressing and Smad4 negative cells were subjected to SDS-PAGE. Flag-
tagged KRT23 and VSV-G-tagged 14-3-3ε were transfected into HEK 293T cells as indicated. B) Confirmation of KRT23-14-3-3ε interaction: cell
lysates were immunoprecipitated with anti-Flag antibody and blotted as indicated. C) KRT23 expression leads to cytoplasmic sequestration of 14-
3-3ε: following fractionation into cytoplasmic and nuclear fractions, proteins were subjected to Western blot analysis with the indicated
antibodies. Anti-lamin B and anti-b-tubulin were used as marker proteins for the purity of the fractions. C, cytoplasmic fraction, N, nuclear
fraction. A representative blot from three independent experiments is shown.
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Page 9 of 14localized in the cytoplasm, whereas in Smad4 negative
cells (with a lower KRT23 expression level) 14-3-3ε
showed a pronounced nuclear localization (Figure 4A).
Next we wanted to test whether the Smad4 dependent
nuclear exclusion of 14-3-3ε could be rescued by
KRT23 knock-down experiments. The KRT23 expres-
sion was monitored by quantitative RT-PCR, because to
the best of our knowledge the direct monitoring of the
expression on the protein level is currently not possible
due to the lack of a specific antibody. KRT23 expression
was successfully reduced by both shRNA vector con-
structs; albeit to different levels depending on the
K R T 2 3s e q u e n c et a r g e t e db yt h et w od i f f e r e n ts h R N A
vector constructs (Figure 4B). In line with the reduced
KRT23 expression following KRT23 knock-down, we
observed a partial rescue of the nuclear 14-3-3ε localiza-
tion which became visible in the shRNA vector con-
struct shKRT1010, showing also the best KRT23 knock-
down efficiency (Figure 4A).
Discussion
Identification of potential Smad4 targets
In this study we aimed to identify and characterize
potential Smad4 target genes involved in colon
Figure 4 Cellular localization of 14-3-3ε according to the Smad4 expression and KRT23 knock-down status of SW480 cells. A) Confocal
immunofluorescence images of SW480 cells. The cellular localization of 14-3-3ε was analyzed in Smad4 negative and Smad4 re-expressing
SW480 cells. KRT23 knock-down was achieved by stable overexpression of shKRT1010 in Smad4 re-expressing cells. The cells were double stained
with antibodies to 14-3-3ε (red) and the cytosolic marker tubulin (green). B) Validation of Keratin 23 knock-down efficiency. The Keratin 23
expression was monitored by quantitative RT-PCR in stably sh-KRT23 overexpressing SW480 cells as indicated. Each condition was measured in
triplicates and normalized to B2M.
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Page 10 of 14carcinogenesis. In order to achieve this, we used our
previously described model system of Smad4 deficient
SW480 cells that re-express Smad4, thereby suppressing
in-vivo tumor formation and invasive potential of
SW480 cells [6]. Using high resolution 2D gel electro-
phoresis, we analyzed nuclear protein fractions from
Smad4 re-expressing and negative SW480 cells. The fol-
lowing MALDI-MS analysis of differentially expressed
protein spots revealed eight different proteins that can
be grouped according to their function in i) gene regula-
tory proteins (hnRNPR; RpAp46; eEFa), ii) stress pro-
teins (gp96; cyclophilin A) and iii) keratins (KRT8;
KRT18 and KRT23). All of these proteins apart from
gp96 and the keratins are considered nuclear proteins,
whereas gp96 is an abundant protein located in the
endoplasmic reticulum (ER). Gp96 is the ER-paralog of
the cytosolic HSP90 with a role in housekeeping, i.e.
maintenance of protein homeostasis in the secretory
pathway [37]. The identification of an abundant ER pro-
tein is not surprising in this context because of the
architecture of the nuclear envelope (NE): The NE con-
sists of two membrane systems, the outer and inner
nuclear membrane; the former being contiguous with
the rough ER. Thus, we expected in our nuclear frac-
tions protein contaminations derived from ER proteins
as well as ribosomal proteins.
The observed presence of keratins in the nuclear frac-
tions can be explained as a cytoplasmic contamination,
by direct interactions between the nuclear lamina and
cytosolic keratins [38] or by association of keratins with
the outer nuclear membrane protein nesprin-3 via the
cytoskeletal linker protein plectin [39]. The fact that our
TAP-experiment also identified plectin, suggests the
latter.
Smad4 modulates Keratin 23 expression
Following the 2D-DIGE analyses which identified the
altered expression of KRT23, we analyzed whether this
increased expression is transcriptionally or post-tran-
scriptionally regulated. Based on the Northern blot ana-
lysis showing a good correlation of KRT23 transcript
and protein expression levels in SW480 cells (Figure
1D) it appears likely that KRT23 is mainly transcription-
ally regulated. A subsequent test of eight human pan-
creatic carcinoma cell lines in which Smad4 expression
was reconstituted by a retroviral expression vector
revealed in three of the eight cell lines a similar Smad4-
dependent KRT23 up-regulation (U. Herbrand, unpub-
lished observation), supporting the notion that KRT23
expression levels can be modulated in two major gastro-
intestinal tumor types directly or indirectly through
Smad4.
A connection between keratin expression and TGF-b
signaling was previously demonstrated in dominant-
negative TGF-b type II receptor mice having elevated
K8/K18 protein levels [40]. In line with this mouse
model data we found that reconstitution of Smad4, a
key downstream component of the TGF-b signaling
pathway, lead to the down-regulation of KRT8. How-
ever, in our model we found that Smad4 reconstitution
increased in KRT18 expression.
In contrast to the increased KRT8/18 expression in
mice in the absence of functioning TGFb-signaling
Zhang et al. showed in a human pancreatic carcinoma
cell lines that sodium butyrate and trichostatin A treat-
ment induces KRT23 expression at the mRNA level
[41]. This effect could be inhibited by RNAi-mediated
knock-down of p21 expression. Interestingly, Smad4
reconstitution in our SW480 model also led to a strong
up-regulation of p21 (I. Schwarte-Waldhoff, unpublished
observation). As p21 is a well described Smad4 target
involved in the TGFb-signaling pathway, these data
would support a model, where Smad4 and p21 are
upstream signaling components involved in the Smad4
dependent up-regulation of KRT23 described herein.
Clearly, more work will be needed in order to elucidate
the key proteins involved in our observed Smad4-depen-
dend up-regulation of KRT23.
Bühler et al. recently reported that expression of
KRT18 caused an induction of adhesion proteins and a
regression of the malignant phenotype in KRT18 over-
expressing breast carcinoma cells [42]. Smad4 loss is a
late event during tumor progression and correlates with
the development of a metastatic tumor in colon carcino-
genesis [2,43], fitting well into a model where Smad4
induced expression of specific keratin types in colon
cells may help to maintain the cell to cell junctions
through desmosomes and hemidesmosomes and thus
supporting an epithelial phenotype. Our data hint
towards a model were Smad4 dependent KRT18 and
KRT23 up-regulation and KRT8 down-regulation med-
iates a tumor suppressor effect presumably by playing a
role in supporting the induction of the epithelial pheno-
type observed upon Smad4 reconstitution, which was
also accompanied by an up-regulation of the invasion
suppressor E-cadherin [32].
Keratin 23-14-3-3ε interaction is Smad4 dependent
Interestingly, Hesse et al.n o t e di nap h y l o g e n e t i ct r e e
analysis that KRT23 is an outstanding member of the
type I keratins localized on chromosome 17 [44]. These
data together with the increasing evidence that inter-
mediate filaments are not only important as structural
proteins but are also involved in modulating and con-
trolling cellular signaling processes and apoptosis mostly
through interaction with keratin associated proteins
(KAPs) prompted us to initiate a more detailed study of
KRT23 using the TAP methodology. Five of the seven
Liffers et al. BMC Cancer 2011, 11:137
http://www.biomedcentral.com/1471-2407/11/137
Page 11 of 14identified KRT23 associated proteins (PLEC1, HSP70,
HSP60, KRT8 and KRT18) were found both in Smad4
re-expressing and negative cells. Both, the 14-3-3ε and g
proteins were only identified in the TAP eluate of
Smad4 re-expressing cells. However, we also found that
14-3-3ε and g protein expression levels are reduced in
Smad4 negative cells. Therefore, we hypothesis that this
reduced protein level was sufficient to prevent the
detection of 14-3-3 proteins by silver staining in our
TAP assay. Nevertheless we would also like to point out
that our data neither exclude nor clearly support the
alternative possibility that Smad4 is directly modulating
by any yet unknown mechanism KRT23-14-3-3 interac-
tion. All of these proteins or their homologs have pre-
viously been shown to interact with other keratins [17],
indicating that our experimental conditions were appro-
priate to identify KAPs. Furthermore, they provide evi-
dence that although KRT23 is more distant to other
KRT family members it is likely to share a number of
interaction properties described for other keratins.
Liao et al. showed that KRT18 is able to bind 14-3-3h,
ξ,a n dε as well as HSP70. In their analyses KRT18-14-3-
3 interaction was independent of HSP70 [45]. Ku et al.
reported that keratin-14-3-3ζ interaction is able to modu-
late the cellular distribution of 14-3-3 proteins [36]. Simi-
larly, it has been shown that keratin 17, is rapidly induced
in wounded stratified epithelia and thus regulating cell
growth through binding to the adaptor protein 14-3-3s.
Furthermore, phosphorylation of KRT17 was important
for the redistribution of 14-3-3s from the nucleus to the
cytoplasm with concomitant stimulation of mTOR activ-
ity and cell growth [46]. These data prompted us to study
the influence of Smad4 reconstitution and thus induction
of KRT23 expression on the cellular distribution of 14-3-
3ε in our model system.
Keratin 23 modulates the distribution of 14-3-3
By Western blot analysis we showed that 14-3-3ε requires
the presence of KRT23 for its cytoplasmic localization. In
addition, laser confocal microscopy showed that the re-
expression of the tumor suppressor Smad4 led both to an
induction of KRT23 expression and cytoplasmic sequestra-
tion of 14-3-3ε. This cytoplasmic sequestration was par-
tially released by KRT23 knock-down in Smad4 re-
expressing cells. The close correlation between altering
keratin expression and changing of 14-3-3 distribution
was previously shown for hepatocytes [35]. In agreement
with the hypothesis of Tzivion et al. that intermediate fila-
ment proteins alter signaling pathways through 14-3-3
sequestration, it seems plausible that Smad4-dependent
up-regulation of KRT23 and/or KRT18 may have a similar
effect on 14-3-3 localization [47].
Margolis et al. provided evidence for a pivotal role of
keratins as potential drivers of mitotic entry of cells
[48]. Due to the preferred binding of 14-3-3 to keratin
in the cytoplasm (designated by Margolis et al.a s“the
14-3-3 sink”), the cytoplasmic availability of keratins and
its binding to 14-3-3 ensures that the 14-3-3 cargo pro-
teins are released enabling them to control downstream
cellular processes. Furthermore, it has been shown that
14-3-3 is able to modulate cytoplasmic localization of
target proteins by directing them toward the CRM1-
mediated nuclear export pathway [26,49,50]. These data
together with our data are suggestive for a model where
KRT23-14-3-3 interaction can mediate the relocalization
of nuclear ligands by several mechanisms that ensure
cytoplasmic sequestration of the bound 14-3-3 complex.
Conclusions
In summary, we provide evidence that Smad4 is able to
induce either directly or indirectly KRT23 expression.
Furthermore, we were able to identify several novel
KRT23 interacting proteins among them 14-3-3ε and g.
Finally, we found that KRT23 expression in Smad4 re-
expressing cells is able to cytoplasmic sequestration of
14-3-3ε. These findings together with the known signal
transduction modulator function of 14-3-3 family mem-
bers suggests that our observed new regulatory circuit
of Smad4 dependent KRT23 up-regulation which in
turn modulates the cytoplasmic sequestration of 14-3-3
i sap r e v i o u s l yu n k n o w nf a c e to ft h et u m o rs u p p r e s s i v e
response we observed upon Smad4 re-expression in our
colon cancer model. Therefore, it will be interesting to
determine in future experiments, which are the potential
proteins whose cellular localization and activity are
modulated by the Smad4 dependent KRT23 sequestra-
tion of the 14-3-3 complex to the cytoplasm in our
SW480 model system and what are their cellular func-
tions in colon tumorigenesis.
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